Facebook Linkedin Twitter
Inside Precision Medicine Fecal Microbiota Transplantation May Help Prevent Graft-Versus-Host Disease after Stem Cell Transplants

Graft versus host disease

Hand holding a capsule with microbiota, probiotics or lyophilized microorganisms for fecal microbiota transplantation (FMT).
News & Features

Fecal Microbiota Transplantation May Help Prevent Graft-Versus-Host Disease after Stem Cell Transplants

0
Human bone marrow under the microscope to illustrate myelofibrosis blood cancer, the diagnosis of which could be aided by new AI tools
News & Features

High-Fiber Diets May Reduce Risk of GVHD after Bone Marrow, Stem Cell Transplants

0
T-Cells
Informatics

Allogeneic Hematopoietic Cell Transplant Outcomes Predicted by Multi-Omics

0
Destruction of leukaemia cell in blood cancer
News & Features

A PATH Forward: Phone-Based Program Alleviates Stress Related to Stem Cell Transplants for Blood Cancer

0
CAR T cell immunotherapy, illustration
News & Features

CD19-Targeted CAR NK Cell Therapy Shows Promise in Treating B-Cell Malignancies

0
cancer development
News & Features

Nanodrones Bring NK Cells to Cancers

0
Mountain Forest Hiker Illustration
News & Features

Cancer: The Next Microbiome Frontier

Helen Albert
0
Cancer Cell
News & Features

New Regimen Improves Graft-Versus-Host Disease Response

0
Stem Cell Treatment
News & Features

Personalized Dosing of Pre-Transplant Drugs Can Improve Stem Cell Transplant Success

0
spine bones injury
News & Features

Mesoblast’s Cell Therapy Proves Effective for Lower Back Pain

0
12Page 1 of 2

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine